We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$4.34B
Cap. Flow %
18.68%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Consumer Discretionary 11.26%
3 Healthcare 10.95%
4 Financials 10.85%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
1976
Trekor Metals
TGB
$2.59B
$174K ﹤0.01%
+105,063
New +$174K
FAS icon
1977
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
$174K ﹤0.01%
3,021
+2,944
+3,823% +$224K
IWB icon
1978
iShares Russell 1000 ETF
IWB
$47.9B
$174K ﹤0.01%
+773
New +$170K
MAG
1979
DELISTED
MAG Silver
MAG
$174K ﹤0.01%
+13,725
New +$184K
IYH icon
1980
iShares US Healthcare ETF
IYH
$3.39B
$173K ﹤0.01%
3,175
-5,775
-65% -$317K
PETQ
1981
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$173K ﹤0.01%
15,140
-69,329
-82% -$770K
PRLD icon
1982
Prelude Therapeutics
PRLD
$402M
$173K ﹤0.01%
30,377
+17,250
+131% +$105K
CBAY
1983
DELISTED
Cymabay Therapeutics
CBAY
$172K ﹤0.01%
19,687
-72,418
-79% -$580K
VGT icon
1984
Vanguard Information Technology ETF
VGT
$139B
$168K ﹤0.01%
+3,488
New +$154K
AAXJ icon
1985
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
$168K ﹤0.01%
2,474
-10,930
-82% -$746K
VDE icon
1986
Vanguard Energy ETF
VDE
$9.97B
$168K ﹤0.01%
+1,469
New +$174K
XHE icon
1987
State Street SPDR S&P Health Care Equipment ETF
XHE
$163M
$167K ﹤0.01%
1,789
+1,219
+214% +$114K
ITM icon
1988
VanEck Intermediate Muni ETF
ITM
$2.14B
$165K ﹤0.01%
+3,553
New +$164K
PHK
1989
PIMCO High Income Fund
PHK
$867M
$165K ﹤0.01%
34,558
-25,002
-42% -$125K
TILT icon
1990
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.18B
$165K ﹤0.01%
1,051
-668
-39% -$104K
PTH icon
1991
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$225M
$165K ﹤0.01%
4,401
-2,025
-32% -$79.2K
IMGN
1992
DELISTED
Immunogen Inc
IMGN
$163K ﹤0.01%
+42,516
New +$181K
VIXY icon
1993
ProShares VIX Short-Term Futures ETF
VIXY
$206M
$163K ﹤0.01%
+900
New +$176K
ETAO
1994
DELISTED
Etao International Co., Ltd. Ordinary Shares
ETAO
$162K ﹤0.01%
+5,088
New +$221K
RMNI icon
1995
Rimini Street
RMNI
$454M
$161K ﹤0.01%
+39,188
New +$177K
BKCC
1996
DELISTED
BlackRock Capital Investment Corporation
BKCC
$161K ﹤0.01%
+46,707
New +$170K
ITOT icon
1997
iShares Core S&P Total US Stock Market ETF
ITOT
$93.8B
$161K ﹤0.01%
1,773
+1,735
+4,566% +$154K
TUSK icon
1998
Mammoth Energy Services
TUSK
$125M
$160K ﹤0.01%
38,008
+22,487
+145% +$134K
IHE icon
1999
iShares US Pharmaceuticals ETF
IHE
$1.48B
$160K ﹤0.01%
2,739
-897
-25% -$54K
ACEL icon
2000
Accel Entertainment
ACEL
$973M
$160K ﹤0.01%
+17,542
New +$158K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.